pCDH-EF1a-eFFly-mCherry Citations (14)

Originally described in: Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
Ebinger S, Ozdemir EZ, Ziegenhain C, Tiedt S, Castro Alves C, Grunert M, Dworzak M, Lutz C, Turati VA, Enver T, Horny HP, Sotlar K, Parekh S, Spiekermann K, Hiddemann W, Schepers A, Polzer B, Kirsch S, Hoffmann M, Knapp B, Hasenauer J, Pfeifer H, Panzer-Grumayer R, Enard W, Gires O, Jeremias I Cancer Cell. 2016 Dec 12;30(6):849-862. doi: 10.1016/j.ccell.2016.11.002. Epub 2016 Dec 1. PubMed Journal

---

Articles Citing pCDH-EF1a-eFFly-mCherry

Articles
Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in mice. Ebinger S, Zeller C, Carlet M, Senft D, Bagnoli JW, Liu WH, Rothenberg-Thurley M, Enard W, Metzeler KH, Herold T, Spiekermann K, Vick B, Jeremias I. Haematologica. 2020 Feb 6. pii: haematol.2019.226282. doi: 10.3324/haematol.2019.226282. PubMed
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma. Zhao X, Wang MY, Jiang H, Lwin T, Park PM, Gao J, Meads MB, Ren Y, Li T, Sun J, Fahmi NA, Singh S, Sehgal L, Wang X, Silva AS, Sotomayor EM, Shain KH, Cleveland JL, Wang M, Zhang W, Qi J, Shah BD, Tao J. Cell Rep. 2021 Mar 16;34(11):108870. doi: 10.1016/j.celrep.2021.108870. PubMed
Effective chimeric antigen receptor T cells against SARS-CoV-2. Guo X, Kazanova A, Thurmond S, Saragovi HU, Rudd CE. iScience. 2021 Nov 19;24(11):103295. doi: 10.1016/j.isci.2021.103295. Epub 2021 Oct 16. PubMed
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML. Roas M, Vick B, Kasper MA, Able M, Polzer H, Gerlach M, Kremmer E, Hecker JS, Schmitt S, Stengl A, Waller V, Hohmann N, Festini M, Ludwig A, Rohrbacher L, Herold T, Subklewe M, Gotze KS, Hackenberger CPR, Schumacher D, Helma-Smets J, Jeremias I, Leonhardt H, Spiekermann K. Blood. 2023 Mar 2;141(9):1023-1035. doi: 10.1182/blood.2021015246. PubMed
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer. Zaballos MA, Acuna-Ruiz A, Morante M, Riesco-Eizaguirre G, Crespo P, Santisteban P. Cell Mol Life Sci. 2022 Sep 3;79(9):504. doi: 10.1007/s00018-022-04530-9. PubMed
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target. Le Q, Hadland B, Smith JL, Leonti A, Huang BJ, Ries R, Hylkema TA, Castro S, Tang TT, McKay CN, Perkins L, Pardo L, Sarthy J, Beckman AK, Williams R, Idemmili R, Furlan S, Ishida T, Call L, Srivastava S, Loeb AM, Milano F, Imren S, Morris SM, Pakiam F, Olson JM, Loken MR, Brodersen L, Riddell SR, Tarlock K, Bernstein ID, Loeb KR, Meshinchi S. J Clin Invest. 2022 Nov 15;132(22):e157101. doi: 10.1172/JCI157101. PubMed
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-beta. Chaudhry K, Geiger A, Dowlati E, Lang H, Sohai DK, Hwang EI, Lazarski CA, Yvon E, Holdhoff M, Jones R, Savoldo B, Cruz CRY, Bollard CM. Mol Ther Methods Clin Dev. 2022 Oct 21;27:415-430. doi: 10.1016/j.omtm.2022.10.010. eCollection 2022 Dec 8. PubMed
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Chakraborty S, Bhat AM, Mushtaq I, Luan H, Kalluchi A, Mirza S, Storck MD, Chaturvedi N, Lopez-Guerrero JA, Llombart-Bosch A, Machado I, Scotlandi K, Meza JL, Ghosal G, Coulter DW, Rowley JM, Band V, Mohapatra BC, Band H. bioRxiv. 2023 Mar 22:2023.01.15.524130. doi: 10.1101/2023.01.15.524130. Preprint. PubMed
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Bai Y, Gotz C, Chincarini G, Zhao Z, Slaney C, Boath J, Furic L, Angel C, Jane SM, Phillips WA, Stacker SA, Farah CS, Darido C. Nat Commun. 2023 Mar 22;14(1):1591. doi: 10.1038/s41467-023-37161-0. PubMed
Role of GD2 and its biosynthetic enzyme GD3 synthase in prostate cancer tumorigenesis. Bhat AM, Mohapatra BC, Luan H, Mushtaq I, Chakraborty S, Dutta S, Stock MD, Meza JL, Lele SM, Lin MF, Cook LM, Corey E, Morrissey C, Coulter DW, Rowley J, Datta K, Band V, Band H. bioRxiv. 2023 Apr 22:2023.03.18.533299. doi: 10.1101/2023.03.18.533299. Preprint. PubMed
TRIM71 reactivation enhances the mitotic and hair cell-forming potential of cochlear supporting cells. Li XJ, Morgan C, Nadar-Ponniah PT, Kolanus W, Doetzlhofer A. EMBO Rep. 2023 Jul 26:e56562. doi: 10.15252/embr.202256562. PubMed
Inflammation primes the kidney for recovery by activating AZIN1 A-to-I editing. Heruye S, Myslinski J, Zeng C, Zollman A, Makino S, Nanamatsu A, Mir Q, Janga SC, Doud EH, Eadon MT, Maier B, Hamada M, Tran TM, Dagher PC, Hato T. bioRxiv [Preprint]. 2023 Nov 9:2023.11.09.566426. doi: 10.1101/2023.11.09.566426. PubMed
Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy. Xue G, Li X, Kalim M, Fang J, Jiang Z, Zheng N, Wang Z, Li X, Abdelrahim M, He Z, Nikiforov M, Jin G, Lu Y. Cancer Cell. 2024 May 13;42(5):780-796.e6. doi: 10.1016/j.ccell.2024.03.001. Epub 2024 Mar 21. PubMed
GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior. Bhat AM, Mohapatra BC, Luan H, Mushtaq I, Chakraborty S, Kumar S, Wu W, Nolan B, Dutta S, Storck MD, Schott M, Meza JL, Lele SM, Lin MF, Cook LM, Corey E, Morrissey C, Coulter DW, Rowley MJ, Natarajan A, Datta K, Band V, Band H. Sci Rep. 2024 Jun 12;14(1):13523. doi: 10.1038/s41598-024-60052-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.